GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » E10

Diamyd Medical AB (FRA:DMN) E10 : €-0.07 (As of Nov. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Diamyd Medical AB's adjusted earnings per share data for the three months ended in Nov. 2024 was €-0.035. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.07 for the trailing ten years ended in Nov. 2024.

During the past 3 years, the average E10 Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Diamyd Medical AB was 2.80% per year. The lowest was -1.70% per year. And the median was 0.55% per year.

As of today (2025-03-19), Diamyd Medical AB's current stock price is €0.734. Diamyd Medical AB's E10 for the quarter that ended in Nov. 2024 was €-0.07. Diamyd Medical AB's Shiller PE Ratio of today is .


Diamyd Medical AB E10 Historical Data

The historical data trend for Diamyd Medical AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB E10 Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.09 -0.10 -0.06 -0.07

Diamyd Medical AB Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.07 -0.07 -0.07

Competitive Comparison of Diamyd Medical AB's E10

For the Biotechnology subindustry, Diamyd Medical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Shiller PE Ratio falls into.



Diamyd Medical AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diamyd Medical AB's adjusted earnings per share data for the three months ended in Nov. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=-0.035/133.0000*133.0000
=-0.035

Current CPI (Nov. 2024) = 133.0000.

Diamyd Medical AB Quarterly Data

per share eps CPI Adj_EPS
201502 -0.016 99.867 -0.021
201505 -0.024 100.285 -0.032
201508 -0.025 99.829 -0.033
201511 -0.017 100.129 -0.023
201602 -0.018 100.253 -0.024
201605 -0.074 100.914 -0.098
201608 -0.015 100.968 -0.020
201611 -0.010 101.517 -0.013
201702 -0.018 102.037 -0.023
201705 -0.030 102.679 -0.039
201708 -0.010 103.138 -0.013
201711 -0.020 103.413 -0.026
201802 -0.020 103.678 -0.026
201805 -0.019 104.632 -0.024
201808 -0.019 105.197 -0.024
201811 -0.019 105.443 -0.024
201902 -0.019 105.641 -0.024
201905 -0.009 106.895 -0.011
201908 -0.013 106.716 -0.016
201911 -0.009 107.345 -0.011
202002 0.046 106.742 0.057
202005 -0.009 106.882 -0.011
202008 -0.019 107.571 -0.023
202011 0.143 107.549 0.177
202102 0.019 108.190 0.023
202105 -0.048 108.838 -0.059
202108 -0.038 109.780 -0.046
202111 -0.049 111.069 -0.059
202202 -0.009 112.834 -0.011
202205 -0.019 116.746 -0.022
202208 -0.056 120.573 -0.062
202211 -0.036 123.803 -0.039
202302 -0.027 126.321 -0.028
202305 -0.026 128.034 -0.027
202308 -0.042 129.560 -0.043
202311 -0.035 130.958 -0.036
202402 -0.027 132.046 -0.027
202405 -0.034 132.818 -0.034
202408 -0.044 132.052 -0.044
202411 -0.035 133.000 -0.035

Add all the adjusted EPS together and divide 10 will get our e10.


Diamyd Medical AB  (FRA:DMN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Diamyd Medical AB E10 Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.